BioRender valuation, funding and investors

BioRender works in scientific illustration creation platform development, based in Toronto, Canada. Founded in 2017, it has about 262 employees.

Tech Companies Growth Equity

VALUATION · TODAY

$9.74B −12% after Growth

Range $6.59B – $13.97B · Grade B

TODAY

+12 MO

$5.00B

$10.00B

$15.00B

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

Seed $1.70M

Series A $15.3M

Growth $900M

ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then

HEADCOUNT · TODAY262 employees

+16%6m growth

+27%1y growth

+5%2y growth

100

200

300

Data from Jan 2021

TODAY

Predicted in 1 yr $8.57B −12% vs today

Predicted next raise $926M if a round comes

Winding-down probability 46%

Last round: Growth · $900M · Dec 2025
Valuation at last round: $8.94B · implied
Headcount: 262 · up
Grade: B
Founded: 2017

How VCMC values companies →

BioRender valuation today

VCMC values BioRender at $9.7B today, with a range of $6.6B to $14.0B and a grade of B. The valuation starts from its last funding round, a growth round in Dec 2025.

Valuation by date (122 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

BioRender: valuation by date, as the model would have shown it on each date
Date	Valuation	Range	Predicted in 1 yr	Phase	Headcount	Trend	Grade	Winding-down probability
1 Jan 2017	$6.49M	$2.36M – $17.8M	$8.90M (+37%)	before first round	–	unknown	D	0%
1 Feb 2017	$6.67M	$2.43M – $18.3M	$9.14M (+37%)	before first round	–	unknown	D	0%
1 Mar 2017	$6.83M	$2.49M – $18.8M	$9.36M (+37%)	before first round	–	unknown	D	0%
1 Apr 2017	$7.01M	$2.55M – $19.3M	$9.62M (+37%)	before first round	–	unknown	D	0%
1 May 2017	$7.20M	$2.62M – $19.8M	$9.87M (+37%)	before first round	–	unknown	D	0%
1 Jun 2017	$7.39M	$2.69M – $20.3M	$10.1M (+37%)	before first round	–	unknown	D	0%
1 Jul 2017	$7.59M	$2.76M – $20.8M	$10.4M (+37%)	before first round	–	unknown	D	0%
1 Aug 2017	$7.79M	$2.84M – $21.4M	$10.7M (+37%)	before first round	–	unknown	D	0%
1 Sep 2017	$8.01M	$2.91M – $22.0M	$11.0M (+37%)	before first round	–	unknown	D	0%
1 Oct 2017	$8.22M	$2.99M – $22.6M	$11.3M (+37%)	before first round	–	unknown	D	0%
1 Nov 2017	$8.44M	$3.07M – $23.2M	$11.6M (+37%)	before first round	–	unknown	D	0%
1 Dec 2017	$8.66M	$3.15M – $23.8M	$11.9M (+37%)	before first round	–	unknown	D	0%
1 Jan 2018	$11.3M	$7.45M – $34.5M	$22.7M (+100%)	after a round	–	unknown	C	0%
2 Jan 2018	$11.4M	$7.45M – $34.5M	$22.7M (+100%)	after a round	–	unknown	C	0%
1 Feb 2018	$12.0M	$7.45M – $34.5M	$22.7M (+89%)	after a round	–	unknown	C	0%
1 Mar 2018	$12.7M	$7.45M – $34.5M	$22.7M (+79%)	after a round	–	unknown	C	0%
1 Apr 2018	$13.4M	$7.45M – $34.5M	$22.7M (+69%)	after a round	–	unknown	C	0%
1 May 2018	$14.2M	$7.45M – $34.5M	$22.7M (+59%)	after a round	–	unknown	C	0%
1 Jun 2018	$15.1M	$7.45M – $34.5M	$22.7M (+50%)	after a round	–	unknown	C	0%
1 Jul 2018	$16.0M	$7.45M – $34.5M	$22.7M (+42%)	after a round	–	unknown	C	0%
1 Aug 2018	$16.9M	$7.45M – $34.5M	$22.7M (+34%)	after a round	–	unknown	C	0%
1 Sep 2018	$18.0M	$7.45M – $34.5M	$22.7M (+26%)	after a round	–	unknown	C	0%
1 Oct 2018	$19.0M	$7.45M – $34.5M	$22.7M (+19%)	after a round	–	unknown	C	0%
1 Nov 2018	$20.2M	$7.45M – $34.5M	$22.7M (+12%)	after a round	–	unknown	C	0%
1 Dec 2018	$21.4M	$7.45M – $34.5M	$22.7M (+6%)	after a round	–	unknown	C	0%
1 Jan 2019	$22.7M	$7.45M – $34.5M	$22.7M (0%)	after a round	–	unknown	C	0%
1 Feb 2019	$22.7M	$7.08M – $34.5M	$22.7M (0%)	after a round	–	unknown	C	0%
1 Mar 2019	$22.7M	$6.76M – $34.5M	$22.7M (0%)	after a round	–	unknown	C	0%
1 Apr 2019	$22.7M	$6.43M – $34.5M	$22.7M (0%)	after a round	–	unknown	C	0%
1 May 2019	$22.7M	$6.12M – $34.5M	$22.7M (0%)	after a round	–	unknown	C	0%
1 Jun 2019	$22.7M	$5.81M – $34.5M	$22.7M (0%)	after a round	–	unknown	C	0%
1 Jul 2019	$22.7M	$5.53M – $34.5M	$22.7M (0%)	after a round	–	unknown	C	0%
1 Aug 2019	$22.7M	$5.26M – $34.5M	$22.7M (0%)	after a round	–	unknown	C	0%
1 Sep 2019	$22.7M	$5.00M – $34.5M	$22.7M (0%)	after a round	–	unknown	C	0%
1 Oct 2019	$22.7M	$4.76M – $34.5M	$22.7M (0%)	after a round	–	unknown	C	0%
1 Nov 2019	$22.7M	$4.52M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 Dec 2019	$22.7M	$4.30M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 Jan 2020	$22.7M	$4.09M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 Feb 2020	$22.7M	$3.89M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 Mar 2020	$22.7M	$3.71M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 Apr 2020	$22.7M	$3.52M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 May 2020	$22.7M	$3.35M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 Jun 2020	$22.7M	$3.19M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 Jul 2020	$22.7M	$3.03M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 Aug 2020	$22.7M	$2.88M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 Sep 2020	$22.7M	$2.74M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 Oct 2020	$22.7M	$2.61M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 Nov 2020	$22.7M	$2.48M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 Dec 2020	$22.7M	$2.36M – $34.5M	$22.7M (0%)	after a round	–	unknown	D	0%
1 Jan 2021	$22.7M	$2.24M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 Feb 2021	$22.7M	$2.13M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 Mar 2021	$22.7M	$2.03M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 Apr 2021	$22.7M	$1.93M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 May 2021	$22.7M	$1.84M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 Jun 2021	$22.7M	$1.75M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 Jul 2021	$22.7M	$1.67M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 Aug 2021	$22.7M	$1.58M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 Sep 2021	$22.7M	$1.50M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 Oct 2021	$22.7M	$1.43M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 Nov 2021	$22.7M	$1.36M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 Dec 2021	$22.7M	$1.30M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 Jan 2022	$22.7M	$1.23M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 Feb 2022	$22.7M	$1.17M – $34.5M	$22.7M (0%)	after a round	28	unknown	D	0%
1 Mar 2022	$22.7M	$5.55M – $34.5M	$22.7M (0%)	after a round	75	growing	C	0%
1 Apr 2022	$22.7M	$5.44M – $34.5M	$22.7M (0%)	after a round	75	growing	C	0%
1 May 2022	$22.7M	$5.34M – $34.5M	$22.7M (0%)	after a round	75	growing	C	0%
1 Jun 2022	$22.7M	$5.24M – $34.5M	$22.7M (0%)	after a round	75	growing	C	0%
1 Jul 2022	$22.7M	$5.14M – $34.5M	$22.7M (0%)	after a round	75	growing	C	0%
1 Aug 2022	$22.7M	$0.87M – $34.5M	$22.7M (0%)	after a round	75	unknown	D	0%
1 Sep 2022	$22.7M	$0.83M – $34.5M	$22.7M (0%)	after a round	75	unknown	D	0%
1 Oct 2022	$22.7M	$0.79M – $34.5M	$22.7M (0%)	after a round	75	unknown	D	0%
1 Nov 2022	$22.7M	$0.75M – $34.5M	$22.7M (0%)	after a round	75	unknown	D	0%
1 Dec 2022	$22.7M	$0.74M – $34.5M	$22.7M (0%)	after a round	75	unknown	D	0%
1 Jan 2023	$22.7M	$0.74M – $34.5M	$22.7M (0%)	after a round	75	unknown	D	0%
1 Feb 2023	$22.7M	$4.75M – $34.5M	$22.7M (0%)	after a round	160	growing	C	0%
1 Mar 2023	$22.7M	$4.75M – $34.5M	$22.7M (0%)	after a round	160	growing	C	0%
1 Apr 2023	$22.7M	$4.75M – $34.5M	$22.7M (0%)	after a round	160	growing	C	0%
20 Apr 2023	$901M	$782M – $1.9B	$1.6B (+80%)	after a round	160	growing	B	0%
1 May 2023	$918M	$782M – $1.9B	$1.6B (+77%)	after a round	160	growing	B	0%
1 Jun 2023	$964M	$782M – $1.9B	$1.6B (+68%)	after a round	160	growing	B	0%
1 Jul 2023	$1.0B	$782M – $1.9B	$1.6B (+60%)	after a round	160	growing	B	0%
1 Aug 2023	$1.1B	$782M – $1.9B	$1.6B (+52%)	after a round	160	growing	B	0%
1 Sep 2023	$1.1B	$782M – $1.9B	$1.6B (+45%)	after a round	160	unknown	B	0%
1 Oct 2023	$1.2B	$782M – $1.9B	$1.6B (+38%)	after a round	160	unknown	B	0%
1 Nov 2023	$1.3B	$782M – $2.0B	$1.7B (+34%)	after a round	200	up	B	0%
1 Dec 2023	$1.3B	$782M – $2.0B	$1.7B (+27%)	after a round	200	up	B	0%
1 Jan 2024	$1.4B	$782M – $2.0B	$1.7B (+21%)	after a round	200	up	B	0%
1 Feb 2024	$1.5B	$782M – $2.0B	$1.7B (+14%)	after a round	200	up	B	0%
1 Mar 2024	$1.6B	$782M – $2.0B	$1.7B (+9%)	after a round	200	up	B	0%
1 Apr 2024	$1.7B	$782M – $2.0B	$1.8B (+3%)	after a round	230	growing	B	0%
1 May 2024	$1.8B	$789M – $2.0B	$1.8B (0%)	after a round	230	growing	B	0%
1 Jun 2024	$1.8B	$806M – $2.0B	$1.8B (0%)	after a round	230	growing	B	0%
1 Jul 2024	$1.8B	$823M – $2.0B	$1.8B (0%)	after a round	230	growing	B	0%
1 Aug 2024	$1.8B	$775M – $2.0B	$1.8B (0%)	after a round	230	up	B	0%
1 Sep 2024	$1.8B	$779M – $2.1B	$1.8B (0%)	after a round	250	up	B	0%
1 Oct 2024	$1.8B	$778M – $2.1B	$1.8B (0%)	after a round	250	up	B	0%
1 Nov 2024	$1.8B	$777M – $2.1B	$1.8B (0%)	after a round	250	up	B	0%
1 Dec 2024	$1.8B	$776M – $2.1B	$1.8B (0%)	after a round	250	up	B	0%
1 Jan 2025	$1.8B	$775M – $2.1B	$1.8B (0%)	after a round	250	up	B	0%
1 Feb 2025	$1.8B	$775M – $2.1B	$1.8B (0%)	after a round	250	up	B	0%
1 Mar 2025	$1.8B	$774M – $2.1B	$1.8B (0%)	after a round	250	up	B	0%
1 Apr 2025	$1.8B	$773M – $2.1B	$1.8B (0%)	after a round	250	up	B	0%
1 May 2025	$1.8B	$464M – $2.1B	$1.8B (0%)	after a round	250	flat	C	0%
1 Jun 2025	$1.8B	$441M – $2.1B	$1.8B (-1%)	after a round	250	flat	C	0%
1 Jul 2025	$1.8B	$420M – $2.1B	$1.8B (-1%)	after a round	250	flat	C	0%
1 Aug 2025	$1.0B	$384M – $1.8B	$781M (-23%)	after a round	211	flat	C	52%
1 Sep 2025	$730M	$362M – $1.7B	$490M (-33%)	after a round	203	down	C	81%
1 Oct 2025	$600M	$346M – $1.6B	$371M (-38%)	after a round	206	down	C	97%
1 Nov 2025	$584M	$329M – $1.7B	$357M (-39%)	after a round	206	down	C	97%
1 Dec 2025	$573M	$316M – $1.7B	$347M (-39%)	after a round	214	down	C	97%
19 Dec 2025	$8.9B	$6.3B – $12.7B	$9.0B (0%)	after a round	214	down	B	97%
1 Jan 2026	$8.9B	$6.3B – $12.7B	$8.9B (-1%)	after a round	214	down	B	97%
1 Feb 2026	$8.9B	$6.3B – $12.7B	$8.6B (-4%)	after a round	214	down	B	97%
1 Mar 2026	$9.1B	$6.4B – $13.0B	$8.6B (-5%)	after a round	226	down	B	89%
1 Apr 2026	$9.1B	$6.4B – $13.1B	$8.5B (-7%)	after a round	226	down	B	82%
1 May 2026	$9.1B	$6.4B – $13.1B	$8.4B (-8%)	after a round	226	down	B	76%
1 Jun 2026	$9.3B	$6.5B – $13.4B	$8.5B (-9%)	after a round	242	up	B	70%
1 Jul 2026	$9.3B	$6.5B – $13.5B	$8.4B (-10%)	after a round	242	up	B	64%
1 Aug 2026	$9.4B	$6.5B – $13.6B	$8.4B (-10%)	after a round	247	up	B	59%
1 Sep 2026	$9.5B	$6.5B – $13.8B	$8.5B (-11%)	after a round	253	up	B	54%
1 Oct 2026	$9.7B	$6.6B – $13.9B	$8.5B (-12%)	after a round	262	up	B	50%
24 Oct 2026	$9.7B	$6.6B – $14.0B	$8.6B (-12%)	after a round	262	up	B	46%

Key facts about BioRender

Founded: 2017
Headquarters: Toronto, Canada
Employees: about 262 +27% in a year
Total raised: $917M
Funding rounds: 3
Last round: Growth Equity Dec 2025

BioRender was founded in 2017 by Katya Shteyn, Ryan Marien and Shiz Aoki.

BioRender funding history

BioRender has 3 funding rounds on record, from Jan 2018 to Dec 2025, $917M in total. The latest disclosed valuation is $900M post-money (Series A, Apr 2023).

Growth Equity 18 Dec 2025
With Dimension.
Sources: biorender.com, osler.com, sidley.com
$900M
Series A 19 Apr 2023
Led by Y Combinator.
$15M
$900M post-money
Seed 1 Jan 2018
Led by Y Combinator; with Ankit Gupta, Brad Flora, Fortius Ventures.
$1.7M

BioRender investors

5 investors have backed BioRender; Y Combinator led at least one round.

Y Combinator lead, 2 rounds
Ankit Gupta
Brad Flora
Fortius Ventures

What BioRender does

BioRender works in tech companies, with 14 recorded offerings and customers in life sciences, pharmaceuticals, biotechnology and healthcare.

Science Suite Inc., known as BioRender, is a Canadian software company that develops and operates a web-based platform for creating and sharing scientific illustrations. The company provides a library of icons and templates for life science fields, as well as AI-driven tools for figure customization and editing. BioRender serves scientists and researchers in sectors such as pharmaceuticals, biotechnology, healthcare, and medical devices, supporting scientific communication and collaboration.

Description from Veridion's company data.

Products and services

Scientific Illustration Creation Platform Development
Scientific Figure Sharing Platform Development
Scientific Icon and Template Library Distribution
AI-Based Figure Customization Tools Development
Scientific Communication Platform Services
Life Science Platform Accessibility Services
Multilingual Scientific Platform Services
Scientific Collaboration Platform Services
Scientific Figure Export Services
Science Communication Platform Services
Scientific Platform Scalability Solutions
Scientific Platform Security Solutions
Scientific Platform User Experience Optimization
Scientific Platform Global Distribution

Markets

Life Sciences
Pharmaceuticals
Biotechnology
Healthcare
Medical Devices

Technology

AI Tools for Customizing and Editing Figures

Business model

Business-to-Business
Software-as-a-Service

Industry codes (NAICS)

513210 Software Publishers 100% match

Questions about BioRender

What is BioRender worth?

Valuation $9.7B (range $6.6B to $14.0B), as of 24 Oct 2026. The last disclosed valuation was $900M (Series A, Apr 2023).

Has BioRender raised money?

BioRender has 3 funding rounds on record, from Jan 2018 to Dec 2025, $917M in total. The latest disclosed valuation is $900M post-money (Series A, Apr 2023).

Who has invested in BioRender?

Y Combinator, Ankit Gupta, Brad Flora, Dimension and Fortius Ventures. Lead investors include Y Combinator.

How many people work at BioRender?

About 262, up 27% over the last year. Headcount grew from 28 in Jan 2021 to 262 in Sep 2026.

What does BioRender do?

BioRender works in tech companies, with 14 recorded offerings and customers in life sciences, pharmaceuticals, biotechnology and healthcare. Its main offerings are scientific illustration creation platform development, scientific figure sharing platform development and scientific icon and template library distribution.

When was BioRender founded, and where is it based?

BioRender was founded in 2017 and is based in Toronto, Canada. It has about 262 employees, up 27% over the last year.

How we value companies Report an issue